339 related articles for article (PubMed ID: 29185466)
41. Inhibitory effects and mechanisms of physiological conditions on the activity of enantiomeric forms of an α-helical antibacterial peptide against bacteria.
Huang J; Hao D; Chen Y; Xu Y; Tan J; Huang Y; Li F; Chen Y
Peptides; 2011 Jul; 32(7):1488-95. PubMed ID: 21664394
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and antibacterial bioactivities of cationic deacetyl linezolid amphiphiles.
Bai PY; Qin SS; Chu WC; Yang Y; Cui DY; Hua YG; Yang QQ; Zhang E
Eur J Med Chem; 2018 Jul; 155():925-945. PubMed ID: 29966917
[TBL] [Abstract][Full Text] [Related]
43. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria.
Batoni G; Maisetta G; Esin S
Biochim Biophys Acta; 2016 May; 1858(5):1044-60. PubMed ID: 26525663
[TBL] [Abstract][Full Text] [Related]
44. Antimicrobial AApeptides.
Sang P; Shi Y; Teng P; Cao A; Xu H; Li Q; Cai J
Curr Top Med Chem; 2017; 17(11):1266-1279. PubMed ID: 27758686
[TBL] [Abstract][Full Text] [Related]
45. A novel antimicrobial peptide YS12 isolated from Bacillus velezensis CBSYS12 exerts anti-biofilm properties against drug-resistant bacteria.
Suchi SA; Nam KB; Kim YK; Tarek H; Yoo JC
Bioprocess Biosyst Eng; 2023 Jun; 46(6):813-828. PubMed ID: 36997801
[TBL] [Abstract][Full Text] [Related]
46. Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.
Novais JS; Moreira CS; Silva ACJA; Loureiro RS; Sá Figueiredo AM; Ferreira VF; Castro HC; da Rocha DR
Microb Pathog; 2018 May; 118():105-114. PubMed ID: 29550501
[TBL] [Abstract][Full Text] [Related]
47. Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria.
Xie J; Zhao Q; Li S; Yan Z; Li J; Li Y; Mou L; Zhang B; Yang W; Miao X; Jiang X; Wang R
Chem Biol Drug Des; 2017 Nov; 90(5):690-702. PubMed ID: 28371431
[TBL] [Abstract][Full Text] [Related]
48. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
[TBL] [Abstract][Full Text] [Related]
49. Membrane active antimicrobial activity and molecular dynamics study of a novel cationic antimicrobial peptide polybia-MPI, from the venom of Polybia paulista.
Wang K; Yan J; Dang W; Liu X; Chen R; Zhang J; Zhang B; Zhang W; Kai M; Yan W; Yang Z; Xie J; Wang R
Peptides; 2013 Jan; 39():80-8. PubMed ID: 23159560
[TBL] [Abstract][Full Text] [Related]
50. Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria.
Schmidt EJ; Boswell JS; Walsh JP; Schellenberg MM; Winter TW; Li C; Allman GW; Savage PB
J Antimicrob Chemother; 2001 May; 47(5):671-4. PubMed ID: 11328782
[TBL] [Abstract][Full Text] [Related]
51. Biological characteristics of a new antibacterial peptide and its antibacterial mechanisms against Gram-negative bacteria.
Pei Z; Ying X; Tang Y; Liu L; Zhang H; Liu S; Zhang D; Wang K; Zhang D; Kong L; Gao Y; Ma H
Pol J Vet Sci; 2018 Sep; 21(3):533-542. PubMed ID: 30468326
[TBL] [Abstract][Full Text] [Related]
52. Antibacterial activity of peptides and bio-safety evaluation: in vitro and in vivo studies against bacterial and fungal pathogens.
Arasu MV; Al-Dhabi NA
J Infect Public Health; 2023 Dec; 16(12):2031-2037. PubMed ID: 37890227
[TBL] [Abstract][Full Text] [Related]
53. Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae).
Čujová S; Slaninová J; Monincová L; Fučík V; Bednárová L; Štokrová J; Hovorka O; Voburka Z; Straka J; Čeřovský V
Amino Acids; 2013 Jul; 45(1):143-57. PubMed ID: 23483218
[TBL] [Abstract][Full Text] [Related]
54. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.
Chou HT; Kuo TY; Chiang JC; Pei MJ; Yang WT; Yu HC; Lin SB; Chen WJ
Int J Antimicrob Agents; 2008 Aug; 32(2):130-8. PubMed ID: 18586467
[TBL] [Abstract][Full Text] [Related]
55. A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics.
He J; Starr CG; Wimley WC
Biochim Biophys Acta; 2015 Jan; 1848(1 Pt A):8-15. PubMed ID: 25268681
[TBL] [Abstract][Full Text] [Related]
56. Analogues of the frog skin peptide alyteserin-2a with enhanced antimicrobial activities against Gram-negative bacteria.
Conlon JM; Mechkarska M; Arafat K; Attoub S; Sonnevend A
J Pept Sci; 2012 Apr; 18(4):270-5. PubMed ID: 22392897
[TBL] [Abstract][Full Text] [Related]
57. Antibacterial activity of lipo-α/sulfono-γ-AA hybrid peptides.
Wei L; Wang M; Gao R; Fatirkhorani R; Cai J
Eur J Med Chem; 2020 Jan; 186():111901. PubMed ID: 31771826
[TBL] [Abstract][Full Text] [Related]
58. Amphipathic sulfonamidobenzamides mimicking small antimicrobial marine natural products; investigation of antibacterial and anti-biofilm activity against antibiotic resistant clinical isolates.
Igumnova EM; Mishchenko E; Haug T; Blencke HM; Sollid JUE; Fredheim EGA; Lauksund S; Stensvåg K; Strøm MB
Bioorg Med Chem; 2018 Sep; 26(17):4930-4941. PubMed ID: 30185388
[TBL] [Abstract][Full Text] [Related]
59. Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria.
Dosler S; Karaaslan E; Alev Gerceker A
J Chemother; 2016 Apr; 28(2):95-103. PubMed ID: 25801062
[TBL] [Abstract][Full Text] [Related]
60. Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.
Xie J; Gou Y; Zhao Q; Wang K; Yang X; Yan J; Zhang W; Zhang B; Ma C; Wang R
J Pept Sci; 2014 Nov; 20(11):876-84. PubMed ID: 25098547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
